Invited Commentary
Commentary on “Prevalence of HCV Infection in Adults with Congenital Heart Disease and Treatment with Direct Antiviral Agents”
Abstract
Advances in heart surgery in the past 50 years have provided a high level of survival in children born with congenital heart defects. The estimated number of adults living with repaired, unrepaired, or as-yet-unrecognized congenital heart defects exceeds 1.4 million.1This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.